{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:35:33Z","timestamp":1793734533830,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02554-y","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:57:04Z","timestamp":1744667824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gene signatures and immune correlations in Parkinson\u2019s disease Braak stages"],"prefix":"10.1186","volume":"30","author":[{"given":"Rui-xue","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"2554_CR1","first-page":"1690341","volume":"2021","author":"W Quan","year":"2021","unstructured":"Quan W, Li J, Jin X, Liu L, Zhang Q, Qin Y, Pei X, Chen J. Identification of potential core genes in Parkinson\u2019s disease using bioinformatics analysis. Parkinson\u2019s Dis. 2021;2021:1690341.","journal-title":"Parkinson's Dis"},{"key":"2554_CR2","unstructured":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 2019, 18(5):459\u2013480."},{"issue":"9996","key":"2554_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"4","key":"2554_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JPD-229002","volume":"12","author":"K McFarthing","year":"2022","unstructured":"McFarthing K, Rafaloff G, Baptista M, Mursaleen L, Fuest R, Wyse RK, Stott SRW. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2022 update. J Parkinsons Dis. 2022;12(4):1073\u201382.","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"2554_CR5","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2589-7500(21)00101-1","volume":"3","author":"KA Severson","year":"2021","unstructured":"Severson KA, Chahine LM, Smolensky LA, Dhuliawala M, Frasier M, Ng K, Ghosh S, Hu J. Discovery of Parkinson\u2019s disease states and disease progression modelling: a longitudinal data study using machine learning. Lancet Digital Health. 2021;3(9):e555\u201364.","journal-title":"Lancet Digital Health"},{"issue":"6","key":"2554_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"issue":"1","key":"2554_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-023-00527-8","volume":"9","author":"X Guo","year":"2023","unstructured":"Guo X, Hu W, Gao Z, Fan Y, Wu Q, Li W. Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson\u2019s disease based on integrative analysis. NPJ Parkinson\u2019s disease. 2023;9(1):82.","journal-title":"NPJ Parkinson's disease"},{"issue":"7","key":"2554_CR8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/ejn.15653","volume":"55","author":"E D\u00fcz","year":"2022","unstructured":"D\u00fcz E, \u00c7ak\u0131r T. A co-expression network based molecular characterization of genes responsive for Braak stages in Parkinson\u2019s disease. Eur J Neurosci. 2022;55(7):1873\u201386.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"2554_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2554_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","volume":"16","author":"CH Hawkes","year":"2010","unstructured":"Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16(2):79\u201384.","journal-title":"Parkinsonism Relat Disord"},{"key":"2554_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"2554_CR12","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-d592.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2554_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"4","key":"2554_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(4):11.","journal-title":"BMC Syst Biol"},{"issue":"7","key":"2554_CR15","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao YR, Zhang Q, Lei Q, Luo M, Xie GY, Wang H, Guo AY. ImmuCellAI: a unique method for comprehensive t-cell subsets abundance prediction and its application in cancer immunotherapy. Adv SciS. 2020;7(7):1902880.","journal-title":"Adv SciS"},{"issue":"1","key":"2554_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(1):234\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2554_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-023-02597-7","volume":"146","author":"C Cappelletti","year":"2023","unstructured":"Cappelletti C, Henriksen SP, Geut H, Rozemuller AJM, van de Berg WDJ, Pihlstr\u00f8m L, Toft M. Transcriptomic profiling of Parkinson\u2019s disease brains reveals disease stage specific gene expression changes. Acta Neuropathol. 2023;146(2):227\u201344.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2554_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","volume":"12","author":"ZD Zhou","year":"2023","unstructured":"Zhou ZD, Yi LX, Wang DQ, Lim TM, Tan EK. Role of dopamine in the pathophysiology of Parkinson\u2019s disease. Transl Neurodegen. 2023;12(1):44.","journal-title":"Transl Neurodegen"},{"issue":"3","key":"2554_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1139\/bcb-2019-0117","volume":"98","author":"M Mehrabani","year":"2020","unstructured":"Mehrabani M, Nematollahi MH, Tarzi ME, Juybari KB, Abolhassani M, Sharifi AM, Paseban H, Saravani M, Mirzamohammadi S. Protective effect of hydralazine on a cellular model of Parkinson\u2019s disease: a possible role of hypoxia-inducible factor (HIF)-1\u03b1. Biochem Cell Biol Biochimie et Biol Cell. 2020;98(3):405\u201314.","journal-title":"Biochem Cell Biol Biochimie et Biol Cell"},{"key":"2554_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.703084","volume":"9","author":"EV Mitroshina","year":"2021","unstructured":"Mitroshina EV, Savyuk MO, Ponimaskin E, Vedunova MV. Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease. Front Cell Dev Biol. 2021;9: 703084.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2554_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.peptides.2012.05.026","volume":"38","author":"O Erba\u015f","year":"2012","unstructured":"Erba\u015f O, Oltulu F, Ta\u015fkiran D. Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment. Peptides. 2012;38(2):312\u20137.","journal-title":"Peptides"},{"issue":"3","key":"2554_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3233\/JAD-191091","volume":"74","author":"H Almansoub","year":"2020","unstructured":"Almansoub H, Tang H, Wu Y, Wang DQ, Mahaman YAR, Salissou MTM, Lu Y, Hu F, Zhou LT, Almansob YAM, et al. Oxytocin alleviates MPTP-induced neurotoxicity in mice by targeting microRNA-26a\/death-associated protein kinase 1 pathway. J Alzheimer\u2019s Dis: JAD. 2020;74(3):883\u2013901.","journal-title":"J Alzheimer's Dis: JAD"},{"issue":"6","key":"2554_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41593-023-01323-6","volume":"26","author":"F Berriat","year":"2023","unstructured":"Berriat F, Lobsiger CS, Boill\u00e9e S. The contribution of the peripheral immune system to neurodegeneration. Nat Neurosci. 2023;26(6):942\u201354.","journal-title":"Nat Neurosci"},{"issue":"10","key":"2554_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","volume":"46","author":"J Lauritsen","year":"2023","unstructured":"Lauritsen J, Romero-Ramos M. The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component. Trends Neurosci. 2023;46(10):863\u201378.","journal-title":"Trends Neurosci"},{"issue":"1","key":"2554_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","volume":"113","author":"J Bas","year":"2001","unstructured":"Bas J, Calopa M, Mestre M, Mollev\u00ed DG, Cutillas B, Ambrosio S, Buendia E. Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism. J Neuroimmunol. 2001;113(1):146\u201352.","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"2554_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","volume":"252","author":"CH Stevens","year":"2012","unstructured":"Stevens CH, Rowe D, Morel-Kopp MC, Orr C, Russell T, Ranola M, Ward C, Halliday GM. Reduced T helper and B lymphocytes in Parkinson\u2019s disease. J Neuroimmunol. 2012;252(1\u20132):95\u20139.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2554_CR27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626\u201335.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2554_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","volume":"19","author":"A DeMaio","year":"2022","unstructured":"DeMaio A, Mehrotra S, Sambamurti K, Husain S. The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation. 2022;19(1):251.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2554_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li Y, Wang C, Han T, Liu H, Sun L, Hong J, Hashimoto M, Wei J. The reciprocal interactions between microglia and T cells in Parkinson\u2019s disease: a double-edged sword. J Neuroinflammation. 2023;20(1):33.","journal-title":"J Neuroinflammation"},{"key":"2554_CR30","doi-asserted-by":"publisher","first-page":"33738","DOI":"10.1038\/srep33738","volume":"6","author":"N Kustrimovic","year":"2016","unstructured":"Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, et al. Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson\u2019s disease. Sci Rep. 2016;6:33738.","journal-title":"Sci Rep"},{"issue":"1","key":"2554_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation. 2018;15(1):205.","journal-title":"J Neuroinflammation"},{"key":"2554_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040693","author":"J Joo","year":"2023","unstructured":"Joo J, Jeong J, Park HJ. Blood biomarkers in patients with Parkinson\u2019s disease: a review in context of anesthetic care. Diagnostics. 2023. https:\/\/doi.org\/10.3390\/diagnostics13040693.","journal-title":"Diagnostics"},{"issue":"1","key":"2554_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0092-8674(95)90239-2","volume":"83","author":"HT McMahon","year":"1995","unstructured":"McMahon HT, Missler M, Li C, S\u00fcdhof TC. Complexins: cytosolic proteins that regulate SNAP receptor function. Cell. 1995;83(1):111\u20139.","journal-title":"Cell"},{"key":"2554_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.gene.2005.07.005","volume":"359","author":"NM Raevskaya","year":"2005","unstructured":"Raevskaya NM, Dergunova LV, Vladychenskaya IP, Stavchansky VV, Oborina MV, Poltaraus AB, Limborska SA. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity. Gene. 2005;359:127\u201337.","journal-title":"Gene"},{"issue":"5","key":"2554_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1471-4159.2009.05874.x","volume":"108","author":"M Kataoka","year":"2009","unstructured":"Kataoka M, Sekiguchi M, Takahashi M. Identification of a minimal segment of complexin II essential for preferential distribution in axons. J Neurochem. 2009;108(5):1109\u201315.","journal-title":"J Neurochem"},{"issue":"6","key":"2554_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1601-183X.2010.00590.x","volume":"9","author":"K Radyushkin","year":"2010","unstructured":"Radyushkin K, El-Kordi A, Boretius S, Castaneda S, Ronnenberg A, Reim K, Bickeb\u00f6ller H, Frahm J, Brose N, Ehrenreich H. Complexin2 null mutation requires a \u201csecond hit\u201d for induction of phenotypic changes relevant to schizophrenia. Genes Brain Behav. 2010;9(6):592\u2013602.","journal-title":"Genes Brain Behav"},{"issue":"3","key":"2554_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/CBM-130336","volume":"13","author":"H Komatsu","year":"2013","unstructured":"Komatsu H, Kakehashi A, Nishiyama N, Izumi N, Mizuguchi S, Yamano S, Inoue H, Hanada S, Chung K, Wei M, et al. Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors. Cancer Biomark: Section A Dis Mark. 2013;13(3):171\u201380.","journal-title":"Cancer Biomark: Section A Dis Mark"},{"issue":"1","key":"2554_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12010-022-04135-9","volume":"195","author":"H Li","year":"2023","unstructured":"Li H, Zhao J, Zhong XL, Xu PY, Du LJ, Fang P, Tan LJ, Li MJ, Zhang CF, Cao TS. CPLX2 regulates ferroptosis and apoptosis through NRF2 pathway in human hepatocellular carcinoma cells. Appl Biochem Biotechnol. 2023;195(1):597\u2013609.","journal-title":"Appl Biochem Biotechnol"},{"issue":"4","key":"2554_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/iid3.276","volume":"7","author":"E Tsuru","year":"2019","unstructured":"Tsuru E, Oryu K, Sawada K, Nishihara M, Tsuda M. Complexin 2 regulates secretion of immunoglobulin in antibody-secreting cells. Immunity Inflam Dis. 2019;7(4):318\u201325.","journal-title":"Immunity Inflam Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02554-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:57:11Z","timestamp":1744667831000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02554-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2554"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02554-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a biographical analysis study and does not require ethical approval. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that all individual participants provided informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}